Frontlight ResearchEarly access
Nephrotic syndrome trials in China
21 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Where
- Beijing, Chengdu, Shanghai
- Age
- 16 years to 75 years
- People
- 84 worldwide
- Run by
- Sanofi
See details and how to joinNCT06500702 - No phaseTaking peopleSuper Chinese Nephrotic Syndrome Registration System (SUCCESS)
- Where
- Guangzhou
- Age
- 14 years and over
- People
- 5,000
- Run by
- Sun Yat-sen University
See details and how to joinNCT03001934 - Phase 3Not yet taking people in ChinaZuberitamab in the First Episode of Paediatric Nephrotic Syndrome
- Where
- Changsha, Guiyang, Shanghai, Wuhan, Wuxi, Xiamen
- Age
- 1 year to 18 years
- People
- 120
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT07765914 - Phase 2Taking peopleEvaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases
- Where
- Beijing, Tianjin
- Age
- 18 years to 75 years
- People
- 45
- Run by
- Everest Medicines (China) Co.,Ltd.
See details and how to joinNCT07614477 - Early phase 1Not yet taking people in ChinaRD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
- Where
- Hangzhou, Nanjing
- Age
- 5 years to 20 years
- People
- 30
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07674147 - Early phase 1Taking peopleCD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
- Where
- Hangzhou
- Age
- 3 years and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07586267 - Phase 2/3Taking peopleA Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 192
- Run by
- Bio-Thera Solutions
See details and how to joinNCT07499700 - Early phase 1Taking peopleAllogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
- Where
- Hangzhou
- Age
- 3 years and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07507201 - Phase 2Taking peopleA Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence
- Where
- Hangzhou
- Age
- 6 years to 18 years
- People
- 30
- Run by
- Mao Jianhua
See details and how to joinNCT07087314 - No phaseNot yet taking people in ChinaStudy of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome
- Where
- Hangzhou
- Age
- 1 year to 16 years
- People
- 312
- Run by
- Mao Jianhua
See details and how to joinNCT07388810 - Phase 1Taking peopleCAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
- Where
- Hangzhou
- Age
- 3 years and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07305116 - Early phase 1Taking peopleAnti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
- Where
- Hangzhou
- Age
- 3 years and over
- People
- 36
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06792799 - Phase 4Not yet taking people in ChinaShort-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study
- Where
- Wenzhou
- Age
- 16 years and over
- People
- 224
- Run by
- First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07151456 - Phase 1Taking peopleStudy of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
- Where
- Hangzhou
- Age
- 2 years and over
- People
- 18
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06553898 - Phase 1Taking peopleBlinatumomab for CNI-Resistant/Intolerant SRNS in Children
- Where
- Hangzhou
- Age
- 2 years to 17 years
- People
- 6
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06607991 - Phase 3Not yet taking people in ChinaRituximab in the First Episode of Paediatric Nephrotic Syndrome
- Where
- Shanghai
- Age
- 1 year to 18 years
- People
- 138
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT05850546 - Phase 3Taking peopleStudy of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome
- Where
- Hangzhou
- Age
- 2 years to 18 years
- People
- 20
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06125405 - No phaseTaking peopleClinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children
- Where
- Xiamen
- Age
- 1 year to 18 years
- People
- 50
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06530004 - No phaseTaking peopleSteroid Diabetes in Patients With Kidney Disease
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06161701 - Phase 3Taking peopleStudy of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized,Open-label Clinical Trial.
- Where
- Beijing, Hangzhou, Kunming, Nanjing, Ningbo, Shanghai, Wenzhou, Wuhan
- Age
- 2 years to 14 years
- People
- 140
- Run by
- Mao Jianhua
See details and how to joinNCT06079788 - No phaseTaking peopleChina Kidney Patient Trials Network
- Where
- Beijing
- Age
- 2 years and over
- People
- 1,200
- Run by
- George (Beijing) Clinical Research Co. Ltd.
See details and how to joinNCT05036850